Skip to main content
. 2022 Mar 7;13:794080. doi: 10.3389/fneur.2022.794080

Table 1.

Demographic and clinical characteristics of the participants.

Characteristics Total cohort Current use Non-use p-value
Total No. 2,140 587 (27.4) 1,553 (72.6)
Gender
 Male 1,407 (65.7) 368 (62.7) 1,039 (66.9) 0.067
 Female 733 (34.3) 219 (37.3) 514 (33.1)
Age, x ± SD 61.8 ± 11.7 62.4 ± 11.1 61.5 ± 11.9 0.152
Residence
 Urban 934 (43.6) 286 (48.7) 648 (41.7) 0.012*
 Rural 1,183 (55.3) 294 (50.1) 889 (57.2)
 Unknown 23 (1.1) 7 (1.2) 16 (1.0)
Smoking 636 (29.7) 167 (28.4) 469 (30.2) 0.4
Alcohol use 520 (24.3) 147 (25.0) 373 (24.0) 0.622
Pre-ICH Medical History
 Ischemic heart disease 96 (4.5) 32 (5.5) 64 (4.1) 0.185
 Diabetes 241 (11.3) 73 (12.4) 168 (10.8) 0.291
 Ischemic stroke 256 (12.0) 96 (16.4) 160 (10.3) <0.001*
 Hyperlipidemia 77 (3.6) 26 (4.4) 51 (3.3) 0.204
 Hematologic disorders 7 (0.3) 3 (0.5) 4 (0.3) 0.401
 Thyroid disease 17 (0.8) 5 (0.9) 12 (0.8) 0.791
 Neoplastic disease 29 (1.4) 11 (1.9) 18 (1.2) 0.202
Duration from onset to enrollment
  ≤ 6 h 1,253 (58.6) 353 (60.1) 900 (58.0) 0.499
 7–24 h 546 (25.5) 144 (24.5) 402 (25.9)
 25–72 h 236 (11) 67 (11.4) 169 (10.9)
 4–7 days 105 (4.9) 23 (3.9) 82 (5.3)
Admission SBP (mmHg) 168 (151–188) 167 (150–181) 170 (152–190) 0.008*
Admission DBP (mmHg) 97 (87–109) 96 (86–106) 98 (88–110) 0.017*
Admission NIHSS 9 (4–15) 9 (3–15) 9 (4–16) 0.551
Admission GCS 14 (11–15) 14 (12–15) 14 (10–15) 0.106
Hematoma volumeb 10.1 (5–23.2) 9.8 (4–20) 11 (5–24.4) 0.006*
Location of hematoma
 Supratentorial 1,757 (82.1) 478 (81.4) 1,279 (82.4) 0.417
 Infratentorial 274 (12.8) 81 (13.8) 193 (12.4)
IVH 328 (15.3) 96 (16.4) 232 (14.9) 0.417
*

p < 0.05.

a

Excluding patients with IVH.

DBP, diastolic blood pressure; GCS, Glasgow Coma Scale; ICH, intracerebral hemorrhage; IVH, intraventricular hemorrhage; NIHSS, National Institutes of Health Stroke Scale; NO., number; SBP, systolic blood pressure.